Member Info for BuenaVista

Oh and it never occurred to you that Avacta might have a connection with SVB? Well apologies for speaking my mind. Remember when I looked around your brain and only found a yappy little puppy? Seems I'm still there.

..but now no more announcements since news that HSBC is taking on SVB's business.

Phew!

https://www.londonstockexchange.com/news-article/AVCT/statement-re-silicon-valley-bank/15871661

Good news! You can all take your heads out of the sand now.

Btw, several companies have already this morning stated they have no dealings with SVB and no doubt more will follow when they realise the importance of making such a statement or can get their asses into gear to put out the statement. In that respect Avacta's internal processes and comms were working well over the weekend.

Tomorrow morning will be interesting. I hope Avacta isn't banking with them.

You think it should be "We will be thrilled to announce a new deployment" or "We're thrilled that we will announce a new deployment"?

One's a noun, the other a verb. You can't have a future tense of a noun!

Agreeing Fast-Track/Breakthrough/Prime/etc-approved trial protocol.

XL size buyers waiting

He almost looks ...American

I wonder why that might be.

1 - Started but not announced (unlikely I think)
2 - Waiting for approval of changes to protocol for Phase 1a and Phase 1b (will be required for FDA, MHRA & EMA)
3 - Waiting for ODD grant for trials (hopefully)
4 - Waiting for both 2 and 3

lol

Binned

At least the same response as with doxorubicin but without the side-effects should be newsworthy in itself.

Why are you incapable of adding to a thread? You've been told how to do it yet you continue to fill the board with your multiple new threads. Complete f'in idiot.

Bit of an over-reaction from Alexa I thought

How terrible! To have lost money on AIM in a week. Oh the iniquitty of it! You must sell up immediately and sink your £300 into a mining company.

@Fredluck, I'm hoping that oxygen, and before that StarBright (I think), have called it right in that the II representatives were never going to be going back to their offices and placing orders the next day. Lots for them to consider re their current portfolios as well as timescale for Avacta to get to a position where the SP would be expected to take off.

Thank you for the clarification. Much appreciated.

"3DBT has engaged with over 60 Cellular Agriculture companies of which 26 have progressed to new business opportunities, representing a 43% conversion rate. From these 26 business opportunities, 22 product evaluations are already underway with a view to incorporating City-MixTM into cultured media formulations. A further two companies have also completed successful evaluations and are expected to begin purchasing the product in April 2023."

22+2 does not equal 26

Plus, there is only mention of 1 secured agreement.

"3DBT has secured its first agreement after completing a successful evaluation of City-MixTM."

So no way do these add up to 26. So please explain how they do add up aimgambler123.

Engaged with 'over 60'. Interest from 26. 43% conversion.

Engaged with 61? Converstion rate 42.6%.

Of the 26, 22 product evaluations underway and 2 have completed. What about the other 2?

RNS states 1 agreement after completing a successful evaluation. What about the other 1 (or still 2)?

These numbers don't add up. Ideas?

Why do you call Science Day a fiasco?

As described on Science Day, it's not so much a Phase 1b trial as a Phase 2/small Phase 3 trial. That would considerably shorten the time to market, particularly as the findings would become obvious before the doxorubicin patients finish their course and might even be switched to AVA6000 on ethical grounds before finishing their course. I wouldn't be surprised to hear news of FDA/MHRA/EMA orphan drug and particularly breakthrough/fast-track designation with news of a change to the trial protocol, or even a new trial protocol, when the next dose escalation is announced.